Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer

Autor: Besse, B. ^*, Tsao, L.C., Chao, D.T., Fang, Y., Soria, J.-C., Almokadem, S., Belani, C.P.

Publikováno v: In Annals of Oncology January 2013 24(1):90-96

Phase I study of veliparib in combination with gemcitabine.

Autor: Stoller R; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Schmitz JC; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Ding F; Biostatistics Facility, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Puhalla S; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Belani CP; Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USA., Appleman L; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Lin Y; Biostatistics Facility, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.; Biostatistics Department, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA., Jiang Y; Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USA., Almokadem S; Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USA., Petro D; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Holleran J; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA., Kiesel BF; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA., Ken Czambel R; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA., Carneiro BA; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Kontopodis E; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA.; Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, Greece., Hershberger PA; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA., Rachid M; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA., Chen A; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Chu E; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Beumer JH; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA. beumerj@gmail.com.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. beumerj@gmail.com.; Department of Pharmaceutical Sciences, School of Pharmacy, Pittsburgh, PA, USA. beumerj@gmail.com.

Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2017 Sep; Vol. 80 (3), pp. 631-643. Date of Electronic Publication: 2017 Aug 02.

Infantile Systemic Hyalinosis.

Autor: Jaiswal, Sharwari¹, Madke, Bhushan¹ drbhushan18@gmail.com, Chandak, Meenakshi¹, Jangid, Shivani¹

Publikováno v: Indian Journal of Paediatric Dermatology. Apr-Jun2024, Vol. 25 Issue 2, p128-131. 4p.

A week in the life of lung cancer survivors: Daily reports of stress, worry, mood, and symptoms.

Autor: Aronson KR; Pennsylvania State University, USA kra105@psu.edu., Wagstaff DA; Pennsylvania State University, USA., Farace E; Penn State Hershey College of Medicine, USA., Muscat J; Penn State Hershey College of Medicine, USA., Belani C; Penn State Hershey Cancer Institute, USA., Almokadem S; Penn State Hershey College of Medicine, USA., Fossum T; University of Minnesota School of Medicine, USA.

Publikováno v: Journal of health psychology [J Health Psychol] 2016 Oct; Vol. 21 (10), pp. 2269-82. Date of Electronic Publication: 2015 Apr 06.

Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma.

Autor: Almokadem S; Penn State Hershey Medical center, 500 University Dr. CH 72, Hershey, PA 17033, USA. salmokadem@hmc.psu.edu.

Publikováno v: Current molecular pharmacology [Curr Mol Pharmacol] 2016; Vol. 9 (3), pp. 226-230.